AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Alternative strategies other than growth hormone for the treatment of immune diseases - Response
Authors: Murphy, WJ Longo, DL
Citation: Wj. Murphy et Dl. Longo, Alternative strategies other than growth hormone for the treatment of immune diseases - Response, TRENDS IMMU, 22(1), 2001, pp. 15-16
Polo-like kinase interacts with proteasomes and regulates their activity
Authors: Feng, Y Longo, DL Ferris, DK
Citation: Y. Feng et al., Polo-like kinase interacts with proteasomes and regulates their activity, CELL GROWTH, 12(1), 2001, pp. 29-37
Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies
Authors: Murphy, WJ Koh, CY Raziuddin, A Bennett, M Longo, DL
Citation: Wj. Murphy et al., Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies, IMMUNOL REV, 181, 2001, pp. 279-289
A hole you can drive a MAC through
Authors: Longo, DL
Citation: Dl. Longo, A hole you can drive a MAC through, BLOOD, 97(9), 2001, pp. 2533-2533
A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma
Authors: Janik, JE Miller, LL Korn, EL Stevens, D Curti, BD Smith, JW Sznol, M Conlon, KC Sharfman, W Urba, WJ Gause, BL Longo, DL
Citation: Je. Janik et al., A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma, BLOOD, 97(7), 2001, pp. 1942-1946
Administration of herpes simplex-thymidine kinase-expressing donor T cellswith a T-cell-depleted allogeneic marrow graft
Authors: Tiberghien, P Ferrand, C Lioure, B Milpied, N Angonin, R Deconinck, E Certoux, JM Robinet, E Saas, P Petracca, B Juttner, C Reynolds, CW Longo, DL Herve, P Cahn, JY
Citation: P. Tiberghien et al., Administration of herpes simplex-thymidine kinase-expressing donor T cellswith a T-cell-depleted allogeneic marrow graft, BLOOD, 97(1), 2001, pp. 63-72
Cytoskeletal involvement in apoptosis
Authors: Srivastava, RK Mattson, MP Longo, DL
Citation: Rk. Srivastava et al., Cytoskeletal involvement in apoptosis, ADV CELL AG, 5, 2001, pp. 237-267
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: Results of a phase II study
Authors: Longo, DL Duffey, PL Gribben, JG Jaffe, ES Curti, BD Gause, BL Janik, JE Braman, VM Esseltine, D Wilson, WH Kaufman, D Wittes, RE Nadler, LM Urba, WJ
Citation: Dl. Longo et al., Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: Results of a phase II study, CANCER J, 6(3), 2000, pp. 146-150
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia
Authors: Arun, B Curti, BD Longo, DL Stevens, D Alvord, WG Gause, BL Watson, T Kopp, WC Janik, JE
Citation: B. Arun et al., Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia, CA J SCI AM, 6(1), 2000, pp. 21-24
Lymphomas: complexity, not chaos
Authors: Longo, DL
Citation: Dl. Longo, Lymphomas: complexity, not chaos, CURR OPIN O, 12(5), 2000, pp. 379-382
Positive and negative selection of antigen-specific B cells in transgenic mice expressing variant forms of the V(H)1 (T15) heavy chain
Authors: Kenny, JJ Derby, EG Yoder, JA Hill, SA Fischer, RT Tucker, PW Claflin, JL Longo, DL
Citation: Jj. Kenny et al., Positive and negative selection of antigen-specific B cells in transgenic mice expressing variant forms of the V(H)1 (T15) heavy chain, INT IMMUNOL, 12(6), 2000, pp. 873-885
Growth hormone as an immunomodulating therapeutic agent
Authors: Murphy, WJ Longo, DL
Citation: Wj. Murphy et Dl. Longo, Growth hormone as an immunomodulating therapeutic agent, IMMUNOL TOD, 21(5), 2000, pp. 211-213
Role for CD40-CD40 ligand interactions in the immune response to solid tumours
Authors: Alexandroff, AB Jackson, AM Paterson, T Haley, JL Ross, JA Longo, DL Murphy, WJ James, K Taub, DD
Citation: Ab. Alexandroff et al., Role for CD40-CD40 ligand interactions in the immune response to solid tumours, MOL IMMUNOL, 37(9), 2000, pp. 515-526
Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse
Authors: Mi, QS Zhou, L Schulze, DH Fischer, RT Lustig, A Rezanka, LJ Donovan, DM Longo, DL Kenny, JJ
Citation: Qs. Mi et al., Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse, P NAS US, 97(11), 2000, pp. 6031-6036
Autoreactive B cells escape clonal deletion by expressing multiple antigenreceptors
Authors: Kenny, JJ Rezanka, LJ Lustig, A Fischer, RT Yoder, J Marshall, S Longo, DL
Citation: Jj. Kenny et al., Autoreactive B cells escape clonal deletion by expressing multiple antigenreceptors, J IMMUNOL, 164(8), 2000, pp. 4111-4119
Synergistic anti-tumoral effect of paclitaxel (taxol)+AS101 in a murine model of B16 melanoma: Association with Ras-dependent signal-transduction pathways
Authors: Kalechman, Y Longo, DL Catane, R Shani, A Albeck, M Sredni, B
Citation: Y. Kalechman et al., Synergistic anti-tumoral effect of paclitaxel (taxol)+AS101 in a murine model of B16 melanoma: Association with Ras-dependent signal-transduction pathways, INT J CANC, 86(2), 2000, pp. 281-288
Truncation of the extracellular region abrogrates cell contact but retainsthe growth-suppressive activity of E-cadherin
Authors: Sasaki, CY Lin, HC Morin, PJ Longo, DL
Citation: Cy. Sasaki et al., Truncation of the extracellular region abrogrates cell contact but retainsthe growth-suppressive activity of E-cadherin, CANCER RES, 60(24), 2000, pp. 7057-7065
Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts
Authors: Raziuddin, A Bennett, M Winkler-Pickett, R Ortaldo, JR Longo, DL Murphy, WJ
Citation: A. Raziuddin et al., Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts, BLOOD, 95(12), 2000, pp. 3840-3844
Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients
Authors: Janik, JE Miller, LL Kopp, WC Taub, DD Dawson, H Stevens, D Kostboth, P Curti, BD Conlon, KC Dunn, BK Donegan, SE Ullrich, R Alvord, WG Gause, BL Longo, DL
Citation: Je. Janik et al., Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients, CLIN IMMUNO, 93(3), 1999, pp. 209-221
Conditioned immune response to interferon-gamma in humans
Authors: Longo, DL Duffey, PL Kopp, WC Heyes, MP Alvord, WG Sharfman, WH Schmidt, PJ Rubinow, DR Rosenstein, DL
Citation: Dl. Longo et al., Conditioned immune response to interferon-gamma in humans, CLIN IMMUNO, 90(2), 1999, pp. 173-181
CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras
Authors: Murphy, WJ Funakoshi, S Fanslow, WC Rager, HC Taub, DD Longo, DL
Citation: Wj. Murphy et al., CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras, CLIN IMMUNO, 90(1), 1999, pp. 22-27
Complete molecular remissions induced by patient-specific vaccination plusgranulocyte-monocyte colony-stimulating factor against lymphoma
Authors: Bendandi, M Gocke, CD Kobrin, CB Benko, FA Sternas, LA Pennington, R Watson, TM Reynolds, CW Gause, BL Duffey, PL Jaffe, ES Creekmore, SP Longo, DL Kwak, LW
Citation: M. Bendandi et al., Complete molecular remissions induced by patient-specific vaccination plusgranulocyte-monocyte colony-stimulating factor against lymphoma, NAT MED, 5(10), 1999, pp. 1171-1177
Synergistic effects of retinoic acid and 8-chloro-adenosine 3 ',5 '-cyclicmonophosphate on the regulation of retinoic acid receptor beta and apoptosis: Involvement of mitochondria
Authors: Srivastava, RK Srivastava, AR Cho-Chung, YS Longo, DL
Citation: Rk. Srivastava et al., Synergistic effects of retinoic acid and 8-chloro-adenosine 3 ',5 '-cyclicmonophosphate on the regulation of retinoic acid receptor beta and apoptosis: Involvement of mitochondria, CLIN CANC R, 5(7), 1999, pp. 1892-1904
Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells
Authors: Srivastava, RK Srivastava, AR Cho-Chung, YS Longo, DL
Citation: Rk. Srivastava et al., Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells, ONCOGENE, 18(9), 1999, pp. 1755-1763
Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine
Authors: Woody, MA Welniak, LA Sun, R Tian, ZG Henry, M Richards, S Raziuddin, A Longo, DL Murphy, WJ
Citation: Ma. Woody et al., Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine, EXP HEMATOL, 27(5), 1999, pp. 811-816
Risultati: 1-25 | 26-34